Baxano, Inc. – Trademark Portfolio
Entity Type: 03
Baxano, Inc. holds 30 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 15 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include IOFLEX, IO-FLEX, IO · FLEX, NEURO CHECK, and MICROBLADE SHAVER. The owner is based in San Jose, CA.
655 River Oaks Parkway
San Jose, CA 95134
Showing of trademarks Trademarks
Trademark Classifications
Baxano, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Baxano, Inc. have?
Baxano, Inc. has 30 U.S. trademarks filed with the USPTO. Of these, 6 registered, 5 abandoned, 19 cancelled.
What trademark classes does Baxano, Inc. file in?
Baxano, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Baxano, Inc.'s most well-known trademarks?
Baxano, Inc.'s registered trademark portfolio includes well-known marks such as IOFLEX, IO-FLEX, IO · FLEX, NEURO CHECK, and MICROBLADE SHAVER. These are among 6 currently registered trademarks in the portfolio.
What is Baxano, Inc.'s trademark registration success rate?
Baxano, Inc. has a 20% trademark registration rate, with 6 out of 30 resolved applications resulting in successful registration. Currently, 0 applications are pending review.